We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, validated [...]
While we have considerable data regarding the reproductive safety of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs), most studies have focused on the prevalence of major malformations in children with prenatal exposure to antidepressants. [...]
We hope everybody is settling into the New Year. Here's a look back at what happened in 2019. Brexanolone takes the lead as our top story for 2019. Brexanolone (introduced as SAGE-547 by SAGE Therapeutics) [...]
We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]
According to recent findings published in Diabetic Medicine, women who develop gestational diabetes may be more likely to experience depression during pregnancy and after delivery, compared to women without gestational diabetes. Over the years, we [...]
Data regarding the reproductive safety of benzodiazepines has always been somewhat difficult to understand. While earlier studies suggested an association between prenatal exposure to benzodiazepines and increased risk of cleft lip and palate, more recent [...]
All women are at risk for depression during pregnancy and the postpartum period, and there is growing evidence to suggest that poor sleep during pregnancy and the postpartum period may be a risk factor for [...]
In women of reproductive age, cannabis is the most commonly used recreational drug, and there the use of cannabis during pregnancy is on the rise. While recent studies have suggested that cannabis use during [...]
When providing information to patients regarding the use of medications during pregnancy, one key element of the decision-making process is an appraisal of the risks associated with untreated psychiatric illness in the mother. While there [...]